Author response for 'Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial'

Authors :: Manav Batra
Jeanne Hejna
Antione Makdissi
Paresh Dandona
Robert Borowski
Sanaa Abuaysheh
Ajay Chaudhuri
Nitesh D. Kuhadiya
Husam Ghanim
Kelly Green
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: medicine.medical_specialty
Type 1 diabetes
Liraglutide
business.industry
Overweight
medicine.disease
law.invention
Randomized controlled trial
law
Internal medicine
medicine
medicine.symptom
business
medicine.drug

Full Text Access

Tools